These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


134 related items for PubMed ID: 35908893

  • 21. Glucuronidation of curcuminoids by human microsomal and recombinant UDP-glucuronosyltransferases.
    Hoehle SI, Pfeiffer E, Metzler M.
    Mol Nutr Food Res; 2007 Aug; 51(8):932-8. PubMed ID: 17628876
    [Abstract] [Full Text] [Related]

  • 22. Glucuronidation of DRF-6574, hydroxy metabolite of DRF-4367 (a novel COX-2 inhibitor) by pooled human liver, intestinal microsomes and recombinant human UDP-glucuronosyltransferases (UGT): role of UGT1A1, 1A3 and 1A8.
    Muzeeb S, Basha SJ, Shashikumar D, Mullangi R, Srinivas NR.
    Eur J Drug Metab Pharmacokinet; 2006 Aug; 31(4):299-309. PubMed ID: 17315542
    [Abstract] [Full Text] [Related]

  • 23. Acyl glucuronidation of fluoroquinolone antibiotics by the UDP-glucuronosyltransferase 1A subfamily in human liver microsomes.
    Tachibana M, Tanaka M, Masubuchi Y, Horie T.
    Drug Metab Dispos; 2005 Jun; 33(6):803-11. PubMed ID: 15769885
    [Abstract] [Full Text] [Related]

  • 24. Identification of human uridine diphosphate-glucuronosyltransferase isoforms responsible for the glucuronidation of 10,11-dihydro-10-hydroxy-carbazepine.
    Huang K, Que L, Ding Y, Chu N, Qian Z, Qin W, Chen Y, Zhang J, He Q.
    J Pharm Pharmacol; 2021 Mar 06; 73(3):388-397. PubMed ID: 33793880
    [Abstract] [Full Text] [Related]

  • 25. Disposition of flavonoids via enteric recycling: UDP-glucuronosyltransferase (UGT) 1As deficiency in Gunn rats is compensated by increases in UGT2Bs activities.
    Wang SW, Kulkarni KH, Tang L, Wang JR, Yin T, Daidoji T, Yokota H, Hu M.
    J Pharmacol Exp Ther; 2009 Jun 06; 329(3):1023-31. PubMed ID: 19264971
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Characterization of raloxifene glucuronidation in vitro: contribution of intestinal metabolism to presystemic clearance.
    Kemp DC, Fan PW, Stevens JC.
    Drug Metab Dispos; 2002 Jun 06; 30(6):694-700. PubMed ID: 12019197
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. UDP-glucuronosyltransferase 1A1 is the principal enzyme responsible for etoposide glucuronidation in human liver and intestinal microsomes: structural characterization of phenolic and alcoholic glucuronides of etoposide and estimation of enzyme kinetics.
    Wen Z, Tallman MN, Ali SY, Smith PC.
    Drug Metab Dispos; 2007 Mar 06; 35(3):371-80. PubMed ID: 17151191
    [Abstract] [Full Text] [Related]

  • 34. Assessment of UDP-glucuronosyltransferase catalyzed formation of Picroside II glucuronide in microsomes of different species and recombinant UGTs.
    Li T, Zheng Y, Fu F, Ji H, Chen X, Zhao Y, Zhao D, Li N, Zhang L.
    Xenobiotica; 2011 Jul 06; 41(7):530-7. PubMed ID: 21524190
    [Abstract] [Full Text] [Related]

  • 35. Characterization of N-glucuronidation of 4-(5-pyridin-4-yl-1H-[1,2,4]triazol-3-yl) pyridine-2-carbonitrile (FYX-051): a new xanthine oxidoreductase inhibitor.
    Omura K, Nakazawa T, Sato T, Iwanaga T, Nagata O.
    Drug Metab Dispos; 2007 Dec 06; 35(12):2143-8. PubMed ID: 17761779
    [Abstract] [Full Text] [Related]

  • 36. Highly selective N-glucuronidation of four piperazine-containing drugs by UDP-glucuronosyltransferase 2B10.
    Lu D, Dong D, Wu B.
    Expert Opin Drug Metab Toxicol; 2018 Sep 06; 14(9):989-998. PubMed ID: 30049229
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Metabolism of the c-Fos/activator protein-1 inhibitor T-5224 by multiple human UDP-glucuronosyltransferase isoforms.
    Uchihashi S, Fukumoto H, Onoda M, Hayakawa H, Ikushiro S, Sakaki T.
    Drug Metab Dispos; 2011 May 06; 39(5):803-13. PubMed ID: 21346002
    [Abstract] [Full Text] [Related]

  • 39. Glucuronidation of anti-HIV drug candidate bevirimat: identification of human UDP-glucuronosyltransferases and species differences.
    Wen Z, Martin DE, Bullock P, Lee KH, Smith PC.
    Drug Metab Dispos; 2007 Mar 06; 35(3):440-8. PubMed ID: 17151190
    [Abstract] [Full Text] [Related]

  • 40. Identification of UGTs and BCRP as potential pharmacokinetic determinants of the natural flavonoid alpinetin.
    Qi C, Fu J, Zhao H, Xing H, Dong D, Wu B.
    Xenobiotica; 2019 Mar 06; 49(3):276-283. PubMed ID: 29436891
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 7.